04U237Z
Supplement Gastric Artery to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | U Supplement |
| Body Part | 2 Gastric Artery |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures reinforce or augment an artery using additional biological or synthetic material without removing the native vessel segment, distinguishing them from Replacement, where the diseased tissue is excised. In the lower arteries this typically takes the form of patch angioplasty at an endarterectomy site, or endovascular placement of a covered stent graft that lines and reinforces a weakened or aneurysmal segment while the native artery remains in place.
Patients undergo this type of procedure when an artery has been narrowed by plaque removal and needs a widening patch to prevent restenosis, or when an aneurysm needs endoluminal reinforcement rather than open resection. It is common in both open vascular surgery and increasingly in endovascular aneurysm repair, where covered stent grafts are deployed to reinforce the arterial wall from within.
Anatomy & Axis Detail
Gastric Artery
The gastric artery, most often referring to the left gastric branch off the celiac trunk, courses along the lesser curvature of the stomach to supply its upper portion and the distal esophagus. Supplement procedures on this small vessel are uncommon but may be performed to reinforce a weakened wall following localized aneurysm or injury encountered during upper gastrointestinal or bariatric surgery, using patch material to bolster the vessel without removing the affected segment. Its close association with the stomach wall and vagal branches means dissection must be precise to avoid disrupting gastric innervation or blood supply to the fundus. The supplement designation applies specifically when native arterial tissue is retained and reinforced rather than excised and replaced with a graft.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should confirm from the operative note that the native artery segment was left in place and that material, whether a bovine pericardial patch, synthetic patch, or covered endograft, was added to reinforce or widen it. The device value must reflect the specific material used, and the body part value should reflect the arterial segment being reinforced, which for endovascular aneurysm repair can span multiple named segments requiring multiple codes.
A frequent error is coding patch angioplasty performed after an endarterectomy as part of the Extirpation code for the plaque removal rather than as a separate Supplement code, when current guidance requires both steps to be captured. Another common mistake is applying Replacement device values to what is actually a reinforcing supplement.